Age-dependent effects of esculetin on mood-related behavior and cognition from stressed mice are associated with restoring brain antioxidant status

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 65, Issue , 2016, Pages 1-16

  Martín Aragón, Sagrario ^a   Villar, Ángel ^a   Benedí, Juana ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Age; Anti depressive; Esculetin; Oxidative stress

Indexed keywords

CATALASE; CYTOCHROME C OXIDASE; ESCULETIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; PROSTAGLANDIN SYNTHASE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; UMBELLIFERONE DERIVATIVE;

ACUTE RESTRAINT STRESS; ADULT; AGE DISTRIBUTION; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANTIOXIDANT STATUS; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CLIMBING TIME; COGNITION; COMPARATIVE STUDY; CONTEXTUAL MEMORY; CONTROLLED STUDY; COORDINATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL BEHAVIORAL TEST; FORCED SWIM TEST; HEALTH STATUS; HOLE BOARD TEST; IMMOBILITY TIME; LOCOMOTION; MALE; MEMORY; MEMORY DISORDER; MITOCHONDRIAL DYNAMICS; MOOD RELATED BEHAVIOR; MOUSE; NEUROMUSCULAR COORDINATION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PASSIVE AVOIDANCE BEHAVIOR; PHYSICAL PARAMETERS; ROTAROD TEST; SPONTANEOUS LOCOMOTOR ACTIVITY; STRESS; TASK PERFORMANCE; TIGHTROPE TEST; TREATMENT DURATION; ACUTE DISEASE; AFFECT; AGING; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; EXERCISE; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PSYCHOLOGY; SWIMMING;

ACUTE DISEASE; ADMINISTRATION, ORAL; AFFECT; AGING; ANIMALS; ANTIOXIDANTS; AVOIDANCE LEARNING; BRAIN; COGNITION; DISEASE MODELS, ANIMAL; MALE; MICE, INBRED C57BL; MOTOR ACTIVITY; OXIDATIVE STRESS; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SWIMMING; UMBELLIFERONES;

EID: 84940404082     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.08.007     Document Type: Article

References (127)

1. Ahmad A., Rasheed N., Ashraf G.M., Kumar R., Banu N., Khan F., Al-Sheeha M., Palit G. Brain region specific monoamine and oxidative changes during restraint stress. Can. J. Neurol. Sci. 2012, 39(3):311-318.
2. Aksenov V., Long J., Liu J., Szechtman H., Khanna P., Matravadia S., Rollo C.D. A complex dietary supplement augments spatial learning, brain mass, and mitochondrial electron transport chain activity in aging mice. Age (Dordr.) 2013, 35(1):23-33.
3. Allam F., Dao A.T., Chugh G., Bohat R., Jafri F., Patki G., Mowrey C., Asghar M., Alkadhi K.A., Salim S. Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats. J. Nutr. 2013, 143(6):835-842.
4. Allen E.N., Cavanaugh J.E. Loss of motor coordination in an aging mouse model. Behav. Brain Res. 2014, 267:119-125.
5. American Psychiatric Association American Psychiatric Association, Diagnostic and Statistical Manual for Mental Disorders 2000, American Psychiatry Press Inc., Washington DC, 2000. 4th ed.
6. Amin S.N., Gamal S.M., Esmail R.S., Aziz T.M., Rashed L.A. Cognitive effects of acute restraint stress in male albino rats and the impact of pretreatment with quetiapine versus ghrelin. J. Integr. Neurosci. 2014, 13(4):669-692.
7. Arnsten A.F.T. Stress signaling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 2009, 10(6):410-422.
8. Barber S.C., Higginbottom A., Mead R.J., Barber S., Shaw P.J. An in vitro screening cascade to identify neuroprotective antioxidants in ALS. Free Radic. Biol. Med. 2009, 46(8):1127-1138.
9. Beers R.F., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952, 195(1):133-140.
10. Behr G.A., Moreira J.C., Frey B.N. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxidative Med. Cell. Longev. 2012, 2012:609421.
11. Berk M., Dean O.M., Cotton S.M., Jeavons S., Tanious M., Kohlmann K., Hewitt K., Moss K., Allwang C., Schapkaitz I., Robbins J., Cobb H., Ng F., Dodd S., Bush A.I., Malhi G.S. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. J. Clin. Psychiatry 2014, 75(6):628-636.
12. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 2001, 64:43-51.
13. Bogdanova O.V., Kanekar S., D'Anci K.E., Renshaw P.F. Factors influencing behavior in the forced swim test. Physiol. Behav. 2013, 118:227-239.
14. Boissier J.R., Simon P. Action of caffeine on the spontaneous motility of the mouse. Arch. Int. Pharmacodyn. Ther. 1965, 158(1):212-221.
15. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 1995, 19(3):377-395.
16. Bourin M., Colombel M.C., Redrobe J.P., Nizard J., Hascoët M., Baker G.B. Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22:343-351.
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
18. Breese G.R., Knapp D.J., Overstreet D.H. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology 2004, 29(3):470-482.
19. Budni J., Zomkowski A.D., Engel D., Santos D.B., dos Santos A.A., Moretti M., Valvassori S.S., Ornell F., Quevedo J., Farina M., Rodrigues A.L. Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Exp. Neurol. 2013, 40:112-121.
20. Bylund D.B., Reed A.L. Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?. Neurochem. Int. 2007, 51(5):246-253.
21. Capra J.C., Cunha M.P., Machado D.G., Zomkowski A.D., Mendes B.G., Santos A.R., Pizzolatti M.G., Rodrigues A.L. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. Eur. J. Pharmacol. 2010, 643(2-3):232-238.
22. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 1999, 19(8):3248-3257.
23. Chakraborti A., Gulati K., Ray A. Age related differences in stress-induced neurobehavioral responses in rats: modulation by antioxidants and nitrergic agents. Behav. Brain Res. 2008, 194(1):86-91.
24. Chang-Ryul Lee, Shin Eun-Joo, Kim Hyoung-Chun, Choi Yeon-Sik, Shin Taekyun, Wie Myung-Bok Esculetin inhibits N-methyl-d-aspartate neurotoxicity via glutathione preservation in primary cortical cultures. Lab. Anim. Res. 2011, 27(3):259-263.
25. Chen Y., Fenoglio K.A., Dubé C.M., Grigoriadis D.E., Baram T.Z. Cellular and molecular mechanisms of hippocampal activation by acute stress are age-dependent. Mol. Psychiatry 2006, 11(11):992-1002.
26. Chiu C.S., Peekhaus N., Weber H., Adamski S., Murray E.M., Zhang H.Z., Zhao J.Z., Ernst R., Lineberger J., Huang L., Hampton R., Arnold B.A., Vitelli S., Hamuro L., Wang W.R., Wei N., Dillon G.M., Miao J., Alves S.E., Glantschnig H., Wang F., Wilkinson H.A. Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 68(10):1181-1192.
27. Chourbaji S., Brandwein C., Vogt M.A., Dormann C., Gass P. Evaluation of effects of previous exposure to an acute stressor before testing for depression-like behaviours in mice. Stress 2008, 11(2):170-175.
28. Clark G., Koester A.G., Pearson D.W. Exploratory behavior in chronic disulfoton poisoning in mice. Psychopharmacologia 1971, 20(2):169-171.
29. Costa A.P., Vieira C., Bohner L.O., Silva C.F., Santos E.C., De Lima T.C., Lino-de-Oliveira C. A proposal for refining the forced swim test in Swiss mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 45:150-155.
30. Couch Y., Anthony D.C., Dolgov O., Revischin A., Festoff B., Santos A.I., Steinbusch H.W., Strekalova T. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav. Immun. 2013, 29:136-146.
31. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 1999, 835(1):18-26.
32. Cryan J.F., Page M.E., Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur. J. Pharmacol. 2002, 436(3):197-205.
33. Dabrowiecki Z., Gordon-Majszak W., Lazarewicz J. Effects of lipid peroxidation on neurotransmitters uptake by rat synaptosomes. Pol. J. Pharmacol. Pharm. 1985, 37(3):325-331.
34. Deacon R.M. Measuring motor coordination in mice. J. Vis. Exp. 2013, 75(e2609).
35. Dean R.L., Scozzafava J., Goas J.A., Regan B., Beer B., Bartus R.T. Age-related differences in behavior across the life span of the C57BL/6J mouse. Exp. Aging Res. 1981, 7(4):427-451.
36. Doremus T.L., Varlinskaya E.I., Spear L.P. Age-related differences in elevated plus maze behavior between adolescent and adult rats. Ann. N. Y. Acad. Sci. 2004, 1021:427-430.
37. Dulcich M.S., Hartman R.E. Pomegranate supplementation improves affective and motor behavior in mice after radiation exposure. Evid. Based Complement. Alternat. Med. 2013, 2013:940830.
38. Elliott S., Rowan A.D., Carrère S., Koshy P., Catterall J.B., Cawston T.E. Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M. Ann. Rheum. Dis. 2001, 60(2):158-165.
39. Forster M.J., Dubey A., Dawson K.M., Stutts W.A., Lal H., Sohal R.S. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(10):4765-4769.
40. Foster T.C. Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-d-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticity. Prog. Neurobiol. 2012, 96:283-303.
41. Freitas A.E., Bettio L.E., Neis V.B., Santos D.B., Ribeiro C.M., Rosa P.B., Farina M., Rodrigues A.L. Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 50:143-150.
42. Fujioka A., Fujioka T., Tsuruta R., Izumi T., Kasaoka S., Maekawa T. Effects of a constant light environment on hippocampal neurogenesis and memory in mice. Neurosci. Lett. 2011, 488(1):41-44.
43. Goveas J.S., Espeland M.A., Hogan P.E., Tindle H.A., Shih R.A., Kotchen J.M., Robinson J.G., Barnes D.E., Resnick S.M. Depressive symptoms and longitudinal changes in cognition: Women's Health Initiative Study of Cognitive Aging. J. Geriatr. Psychiatry Neurol. 2014, 27(2):94-102.
44. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 1980, 106(1):207-212.
45. Gu Y.L., Zhang L.W., Ma N., Ye L.L., Wang de X., Gao X. Cognitive improvement of mice induced by exercise prior to traumatic brain injury is associated with cytochrome c oxidase. Neurosci. Lett. 2014, 570:86-91.
46. Gu F., Chauhan V., Chauhan A. Glutathione redox imbalance in brain disorders. Curr. Opin. Clin. Nutr. Metab. Care 2015, 18(1):89-95.
47. Guang H.M., Du G.H. Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats. Eur. J. Pharmacol. 2006, 542(1-3):77-83.
48. Guercio G.D., Bevictori L., Vargas-Lopes C., Madeira C., Oliveira A., Carvalho V.F., d'Avila J.C., Panizzutti R. d-serine prevents cognitive deficits induced by acute stress. Neuropharmacology 2014, 86:1-8.
49. Gulati K., Chakraborti A., Ray A. Differential role of nitric oxide (NO) in acute and chronic stress induced neurobehavioral modulation and oxidative injury in rats. Pharmacol. Biochem. Behav. 2009, 92(2):272-276.
50. Halliwell B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007, 35(Pt 5):1147-1150.
51. Harro J., Kanarik M., Matrov D., Panksepp J. Mapping patterns of depression-related brain regions with cytochrome oxidase histochemistry: relevance of animal affective systems to human disorders, with a focus on resilience to adverse events. Neurosci. Biobehav. Rev. 2011, 35(9):1876-1889.
52. Hemshekhar M., Sunitha K., Thushara R.M., Sebastin Santhosh M., Shanmuga Sundaram M., Kemparaju K., Girish K.S. Antiarthritic and antiinflammatory propensity of 4-methylesculetin, a coumarin derivative. Biochimie 2013, 95(6):1326-1335.
53. Hevner R.F., Wong-Riley M.T. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J. Neurosci. 1991, 11(7):1942-1958.
54. Homberg J.R., Olivier J.D., Blom T., Arentsen T., van Brunschot C., Schipper P., Korte-Bouws G., van Luijtelaar G., Reneman L. Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One 2011, 6(1):e16646.
55. Hybels C.F., Blazer D.G., Landerman L.R., Steffens D.C. Heterogeneity in symptom profiles among older adults diagnosed with major depression. Int. Psychogeriatr. 2011, 23(6):906-922.
56. Ingram D.K., Wiener H.L., Chachich M.E., Long J.M., Hengemihle J., Gupta M. Chronic treatment of aged mice with l-deprenyl produces marked striatal MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation. Neurobiol. Aging 1993, 14(5):431-440.
57. Jaffard R., Cardo B. Passive avoidance in two inbred strains of mice: conditioned emotional response and specific avoidance. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 1976, 282(2):207-209.
58. Jarvik M.E., Kopp R. An improved one-trial passive avoidance learning situation. Psychol. Rep. 1967, 21(1):221-224.
59. Jeste N.D., Hays J.C., Steffens D.C. Clinical correlates of anxious depression among elderly patients with depression. J. Affect. Disord. 2006, 90(1):37-41.
60. Jones B.J., Roberts D.J. A rotarod suitable for quantitative measurements of motor incoordination in naive mice. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1968, 259(2):211.
61. Joseph J.A. The putative role of free radicals in the loss of neuronal functioning in senescence. Integr. Physiol. Behav. Sci. 1992, 27(3):216-227.
62. Jung H.A., Park J.J., Islam M.N., Jin S.E., Min B.S., Lee J.H., Sohn H.S., Choi J.S. Inhibitory activity of coumarins from Artemisia capillaris against advanced glycation endproduct formation. Arch. Pharm. Res. 2012, 35(6):1021-1035.
63. Kang S.Y., Lee K.Y., Park M.J., Kim Y.C., Markelonis G.J., Oh T.H., Kim Y.C. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol. Learn. Mem. 2003, 79(1):11-18.
64. Karmase A., Birari R., Bhutani K.K. Evaluation of anti-obesity effect of Aegle marmelos leaves. Phytomedicine 2013, 20(10):805-812.
65. Kato A., Minoshima Y., Yamamoto J., Adachi I., Watson A.A., Nash R.J. Protective effects of dietary chamomile tea on diabetic complications. J. Agric. Food Chem. 2008, 56(17):8206-8211.
66. Kedia S., Chattarji S. Marble burying as a test of the delayed anxiogenic effects of acute immobilisation stress in mice. J. Neurosci. Methods 2014, 233:150-154.
67. Kim D.H., Kim do Y., Kim Y.C., Jung J.W., Lee S., Yoon B.H., Cheong J.H., Kim Y.S., Kang S.S., Ko K.H., Ryu J.H. Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory disruption in mice. Life Sci. 2007, 80(21):1944-1950.
68. Kim S.H., Kang K.A., Zhang R., Piao M.J., Ko D.O., Wang Z.H., Chae S.W., Kang S.S., Lee K.H., Kang H.K., Kang H.W., Hyun J.W. Protective effect of esculetin against oxidative stress-induced cell damage via scavenging reactive oxygen species. Acta Pharmacol. Sin. 2008, 29(11):1319-1326.
69. Kolyva C., Ghosh A., Tachtsidis I., Highton D., Cooper C.E., Smith M., Elwell C.E. Cytochrome c oxidase response to changes in cerebral oxygen delivery in the adult brain shows higher brain-specificity than haemoglobin. Neuroimage 2014, 85(Pt 1):234-244.
70. Kumar A., Goyal R. Quercetin protects against acute immobilization stress-induced behaviors and biochemical alterations in mice. J. Med. Food 2008, 11(3):469-473.
71. Kumar A., Garg R., Prakash A.K. Effect of St. John's Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in mice. BMC Complement. Altern. Med. 2010, 10:18.
72. Lacy A., O'Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr. Pharm. Des. 2004, 10(30):3797-3811.
73. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 1976, 71(4):952-958.
74. Lee C.R., Shin E.J., Kim H.C., Choi Y.S., Shin T., Wie M.B. Esculetin inhibits N-methyl-d-aspartate neurotoxicity via glutathione preservation in primary cortical cultures. Lab. Anim. Res. 2011, 27:259-263.
75. Lee A.S., Ellman M.B., Yan D., Kroin J.S., Cole B.J., van Wijnen A.J., Im H.J. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013, 527(2):440-447.
76. Leite-Almeida H., Almeida-Torres L., Mesquita A.R., Pertovaara A., Sousa N., Cerqueira J.J., Almeida A. The impact of age on emotional and cognitive behaviours triggered by experimental neuropathy in rats. Pain 2009, 144(1-2):57-65.
77. Liu R., Liu I.Y., Bi X., Thompson R.F., Doctrow S.R., Malfroy B., Baudry M. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(14):8526-8531.
78. Ljungberg T., Ungerstedt U. Automatic registration of behaviour related to dopamine and noradrenaline transmission. Eur. J. Pharmacol. 1976, 36(1):181-188.
79. Lopresti A.L., Maes M., Maker G.L., Hood S.D., Drummond P.D. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J. Affect. Disord. 2014, 167:368-375.
80. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47(3):469-474.
81. Martín-Aragón S., Benedí J., Villar A. Oxygen active species-scavenger properties of coumarins. Phytother. Res. 1996, 10(Suppl. 1):S75-S78.
82. Martín-Aragón S., Benedi J.M., Villar A.M. Effects of the antioxidant (6,7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice. Gerontology 1998, 44(1):21-25.
83. Mason S.S., Baker K.B., Davis K.W., Pogorelov V.M., Malbari M.M., Ritter R., Wray S.P., Gerhardt B., Lanthorn T.H., Savelieva K.V. Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur. J. Pharmacol. 2009, 602(2-3):306-315.
84. Massey V., Williams C.H. On the reaction mechanism of yeast glutathione reductase. J. Biol. Chem. 1965, 240(11):4470-4480.
85. Miquel J., Blasco M.A. Simple technique for evaluation of vitality loss in aging mice, by testing their muscular coordination and vigor. Exp. Gerontol. 1978, 13:389-396.
86. Mitra R., Jadhav S., McEwen B.S., Vyas A., Chattarji S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. PNAS 2005, 102(26):9371-9376.
87. Moretti M., Budni J., Dos Santos D.B., Antunes A., Daufenbach J.F., Manosso L.M., Farina M., Rodrigues A.L. Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice. J. Mol. Neurosci. 2013, 49(1):68-79.
88. Morrison J.H., Baxter M.G. The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat. Rev. Neurosci. 2012, 13:240-250.
89. Murugesan N., Demarest T.G., Madri J.A., Pachter J.S. Brain regional angiogenic potential at the neurovascular unit during normal aging. Neurobiol. Aging 2012, 33(5):1004. (e1-16).
90. Nagai J., Kurokawa M., Takeshima H., Kieffer B.L., Ueda H. Circadian-dependent learning and memory enhancement in nociceptin receptor-deficient mice with a novel KUROBOX apparatus using stress-free positive cue task. J. Pharmacol. Exp. Ther. 2007, 321(1):195-201.
91. Naitoh H., Yamaoka K., Nomura S. Behavioral assessment of antidepressants (1)-the forced swimming test: a review of its theory and practical application. Yakubutsu Seishin Kodo 1992, 12(3):105-111.
92. Norris M.P., West R.L. Activity memory and aging: the role of motor retrieval and strategic processing. Psychol. Aging 1993, 8(1):81-86.
93. Okazawa H., Ikawa M., Tsujikawa T., Kiyono Y., Yoneda M. Brain imaging for oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Q. J. Nucl. Med. Mol. Imaging 2014, 58(4):387-397.
94. Olivier J.D., Blom T., Arentsen T., Homberg J.R. The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(6):1400-1408.
95. Page M.E., Brown K., Lucki I. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action. Psychopharmacology (Berlin) 2003, 165(2):194-201.
96. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70(1):158-169.
97. Pan S., Shi M., Jin J., Albin R.L., Lieberman A., Gearing M., Lin B., Pan C., Yan X., Kashima D.T., Zhang J. Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Mol. Cell. Proteomics 2007, 6(10):1818-1823.
98. Pandya C.D., Howell K.R., Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 46:214-223.
99. Park J.H., Kim S.R., An H.J., Kim W.J., Choe M., Han J.A. Esculetin promotes type I procollagen expression in human dermal fibroblasts through MAPK and PI3K/Akt pathways. Mol. Cell. Biochem. 2012, 368(1-2):61-67.
100. Patki G., Ali Q., Pokkunuri I., Asghar M., Salim S. Grape powder treatment prevents anxiety-like behavior in a rat model of aging. Nutr. Res. 2015, 35(6):504-511.
101. Peng X.M., Damu G.L., Zhou C. Current developments of coumarin compounds in medicinal chemistry. Curr. Pharm. Des. 2013, 19(21):3884-3930.
102. Pieramico V., Esposito R., Cesinaro S., Frazzini V., Sensi S.L. Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals. Front. Syst. Neurosci. 2014, 8:153.
103. Poleszak E., Wlaz P., Kedzierska E., Nieoczym D., Wyska E., Szymura-Oleksiak J., Fidecka S., Radziwon-Zaleska M., Nowak G. Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine. Pharmacol. Rep. 2006, 58:746-752.
104. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229(2):327-336.
105. Prakash A., Shur B., Kumar A. Naringin protects memory impairment and mitochondrial oxidative damage against aluminum-induced neurotoxicity in rats. Int. J. Neurosci. 2013, 123(9):636-645.
106. Rezin G.T., Cardoso M.R., Gonçalves C.L., Scaini G., Fraga D.B., Riegel R.E., Comim C.M., Quevedo J., Streck E.L. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem. Int. 2008, 53(6-8):395-400.
107. Riskind J.H., Kleiman E.M., Weingarden H., Danvers A.F. Cognitive vulnerability to anxiety in the stress generation process: further investigation of the interaction effect between the looming cognitive style and anxiety sensitivity. J. Behav. Ther. Exp. Psychiatry 2013, 44(4):381-387.
108. Rosa J.M., Dafre A.L., Rodrigues A.L. Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation. Behav. Brain Res. 2013, 253:165-172.
109. Scapagnini G., Davinelli S., Drago F., De Lorenzo A., Oriani G. Antioxidants as antidepressants: fact or fiction?. CNS Drugs 2012, 26(6):477-490.
110. Shiotsuki H., Yoshimi K., Shimo Y., Funayama M., Takamatsu Y., Ikeda K., Takahashi R., Kitazawa S., Hattori N. A rotarod test for evaluation of motor skill learning. J. Neurosci. Methods 2010, 189(2):180-185.
111. Shukitt-Hale B., Smith D.E., Meydani M., Joseph J.A. The effects of dietary antioxidants on psychomotor performance in aged mice. Exp. Gerontol. 1999, 34(6):797-808.
112. Siwek M., Sowa-Kućma M., Dudek D., Styczeń K., Szewczyk B., Kotarska K., Misztakk P., Pilc A., Wolak M., Nowak G. Oxidative stress markers in affective disorders. Pharmacol. Rep. 2013, 65(6):1558-1571.
113. Smith L. Spectrophotometric assay of cytochrome c oxidase. Methods Biochem. Anal. 1955, 2:427-434.
114. Solanki N., Alkadhi I., Atrooz F., Patki G., Salim S. Grape powder prevents cognitive, behavioral, and biochemical impairments in a rat model of posttraumatic stress disorder. Nutr. Res. 2015, 35(1):65-75.
115. Subramaniam S.R., Ellis E.M. Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease. J. Neurosci. Res. 2013, 91(3):453-461.
116. Sundt T.M., Anderson R.E. Intracellular brain pH and the pathway of a fat soluble pH indicator across the blood-brain barrier. Brain Res. 1980, 186(2):355-364.
117. Sung Y.Y., Kim D.S., Kim H.K. Viola mandshurica ethanolic extract prevents high-fat-diet-induced obesity in mice by activating AMP-activated protein kinase. Environ. Toxicol. Pharmacol. 2014, 38(1):41-50.
118. Takeda H., Tsuji M., Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol. 1998, 350(1):21-29.
119. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 1969, 27(3):502-522.
120. Tyler D.D., Nathanailides C. Assaying for maximal cytochrome c oxidase activity in fish muscle. BAM 1995, 5(1):99-102.
121. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
122. Van Gaalen M.M., Steckler T. Behavioural analysis of four mouse strains in an anxiety test battery. Behav. Brain Res. 2000, 115(1):95-106.
123. Wang C., Pei A., Chen J., Yu H., Sun M.L., Liu C.F., Xu X. A natural coumarin derivative esculetin offers neuroprotection on cerebral ischemia/reperfusion injury in mice. J. Neurochem. 2012, 121(6):1007-1013.
124. Wiechman B.E., Wood T.E., Spratto G.R. Locomotor activity in morphine-treated rats: effects of and comparisons between cocaine, procaine, and lidocaine. Pharmacol. Biochem. Behav. 1981, 15(3):425-433.
125. Xu Y., Wang C., Klabnik J.J., O'Donnell J.M. Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment. Curr. Neuropharmacol. 2014, 12(2):108-109.
126. Zafir A., Ara A., Banu N. In vivo antioxidant status: a putative target of antidepressant action. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(2):220-228.
127. Zhang L., Luo J., Zhang M., Yao W., Ma X., Yu S.Y. Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats. Int. J. Neuropsychopharmacol. 2014, 17(5):793-806.